醫院管理局藥物名冊 [只備英文版]
版本 22.1 – 自 2026 年 7 月 25 日起生效
2.藥物可有不同劑型或臨床應用，因此部分名冊藥物可能會出現在多個藥物類別。
3.專用藥物需要在特定的臨床應用及臨床情況適用下處方。
4.不同聯網/醫院會按其運作及服務需要，庫存醫管局藥物名冊內適當的藥物。
| 通用藥物 | 專用藥物 | 獲安全網資助的 自費購買藥物(自費藥物) |
不獲安全網資助的 自費藥物 |
|---|---|---|---|
 心臟科
|
|||
| 通用藥物 | 專用藥物 | 獲安全網資助的 自費購買藥物(自費藥物) |
不獲安全網資助的 自費藥物 |
| POSITIVE INOTROPIC DRUGS | |||
| DIGOXIN | MILRINONE | ||
| DIURETICS | |||
| AMILORIDE | EPLERENONE | ||
| BUMETANIDE | FINERENONE | ||
| DYAZIDE (OR EQUIV) | |||
| FRUSEMIDE | |||
| HYDROCHLOROTHIAZIDE | |||
| INDAPAMIDE | |||
| MANNITOL | |||
| MANNITOL + SORBITOL | |||
| METOLAZONE | |||
| MODURETIC (OR EQUIV) | |||
| SPIRONOLACTONE | |||
| ANTI-ARRHYTHMIC DRUGS | |||
| AMIODARONE | DRONEDARONE | ||
| ATROPINE | |||
| DISOPYRAMIDE | |||
| FLECAINIDE | |||
| MEXILETINE | |||
| PROCAINAMIDE | |||
| PROPAFENONE | |||
| QUINIDINE | |||
| BETA-ADRENOCEPTOR BLOCKING DRUGS | |||
| ATENOLOL | |||
| BISOPROLOL | |||
| BISOPROLOL + HYDROCHLOROTHIAZIDE | |||
| CARVEDILOL | |||
| ESMOLOL | |||
| LABETALOL | |||
| METOPROLOL | |||
| NADOLOL | |||
| PROPRANOLOL | |||
| SOTALOL | |||
| HYPERTENSION AND HEART FAILURE | |||
| CAPTOPRIL | AMBRISENTAN | ||
| CLONIDINE | AMLODIPINE + VALSARTAN | ||
| ENALAPRIL | BOSENTAN | ||
| ENALAPRILAT | CANDESARTAN | ||
| HYDRALAZINE | DOXAZOSIN | ||
| LISINOPRIL | ILOPROST | ||
| LOSARTAN | IRBESARTAN | ||
| METHYLDOPA | IRBESARTAN + HYDROCHLOROTHIAZIDE | ||
| MINOXIDIL | LOSARTAN + HYDROCHLOROTHIAZIDE | ||
| NITROPRUSSIDE DIHYDRATE SODIUM | MACITENTAN | ||
| PERINDOPRIL | RIOCIGUAT | ||
| PHENOXYBENZAMINE | SACUBITRIL + VALSARTAN | ||
| PHENTOLAMINE | SELEXIPAG | ||
| PRAZOSIN | SILDENAFIL (REVATIO) | ||
| RAMIPRIL | TELMISARTAN + HYDROCHLOROTHIAZIDE | ||
| TELMISARTAN | VALSARTAN | ||
| TERAZOSIN | VALSARTAN + HYDROCHLOROTHIAZIDE | ||
| NITRATES, CALCIUM-CHANNEL BLOCKERS, AND OTHER ANTIANGINAL DRUGS | |||
| AMLODIPINE | CILOSTAZOL | CEREBROLYSIN (OR EQUIV) | |
| DILTIAZEM | GINKGO BILOBA EXTRACT | ||
| FELODIPINE ER | IVABRADINE | ||
| GLYCERYL TRINITRATE | LERCANIDIPINE | ||
| GLYCERYL TRINITRATE (PATCH) | NIFEDIPINE | ||
| ISOSORBIDE DINITRATE | OXPENTIFYLLINE | ||
| ISOSORBIDE MONONITRATE | |||
| NICARDIPINE | |||
| NICERGOLINE | |||
| NIFEDIPINE | |||
| NIMODIPINE | |||
| VERAPAMIL | |||
| SYMPATHOMIMETICS | |||
| ADRENALINE | |||
| DOBUTAMINE | |||
| DOPAMINE | |||
| EPHEDRINE | |||
| ISOPRENALINE | |||
| MIDODRINE | |||
| NORADRENALINE | |||
| PHENYLEPHRINE | |||
| ANTICOAGULANTS AND PROTAMINE | |||
| ARGATROBAN | APIXABAN | ||
| ENOXAPARIN | DABIGATRAN | ||
| EPOPROSTENOL | EDOXABAN | ||
| HEPARIN | RIVAROXABAN | ||
| NADROPARIN | |||
| PROTAMINE SULPHATE | |||
| TINZAPARIN | |||
| WARFARIN | |||
| ANTIPLATELET DRUGS | |||
| ASPIRIN | CLOPIDOGREL | ||
| ASPIRIN + GLYCINE | EPTIFIBATIDE | ||
| DIPYRIDAMOLE | PRASUGREL | ||
| TICAGRELOR | |||
| STABLE ANGINA, ACUTE CORONARY SYNDROMES, AND FIBRINOLYSIS | |||
| ALTEPLASE | |||
| TENECTEPLASE | |||
| UROKINASE | |||
| ANTIFIBRINOLYTIC DRUGS AND HAEMOSTATICS | |||
| TRANEXAMIC ACID | EMICIZUMAB | ||
| FACTOR IX | |||
| FACTOR VIIA | |||
| FACTOR VIII | |||
| FACTOR VIII INHIBITOR BYPASSING FRACTION | |||
| FIBRINOGEN HUMAN | |||
| PROTHROMBIN COMPLEX CONCENTRATE | |||
| LIPID-REGULATING DRUGS | |||
| ATORVASTATIN | ALIROCUMAB | ||
| EZETIMIBE | BEMPEDOIC ACID | ||
| GEMFIBROZIL | CHOLESTYRAMINE | ||
| ROSUVASTATIN | EVOLOCUMAB | ||
| SIMVASTATIN | FENOFIBRATE | ||
| INCLISIRAN | |||
| LOCAL SCLEROSANTS | |||
| ETHANOLAMINE OLEATE | |||
| SODIUM TETRADECYL SULPHATE | |||
| MISCELLANEOUS (CARDIOVASCULAR SYSTEM) | |||
| ADENOSINE TRIPHOSPHATE DISODIUM | LEVOSIMENDAN | TAFAMIDIS | |
| CARDIOPLEGIA (OR EQUIV) | MAVACAMTEN | ||
| DAFLON (OR EQUIV) | TRIMETAZIDINE | ||
| TISSEEL KIT (OR EQUIV) | |||
| UBIDECARENONE | |||